1Miettinen M. Sarlomo-Rikala M, Sobin LH, et al. Esophageal stromal tumors:a clinicopathologic,immunohistochemical and molecular genetic study of 17 cases and comparison with esophagcal leiomyomas and leiomyosarcomas.Am J Surg Pathol,2000,24(2):211
2Tworek JA, Goldblum JR., Weiss SW, et al. Stromal tumors of the abdominal colon:a clinicopathologic study of 20 cases. Am J Surg Pathol,1999,23(8):937.
3Miettinen M, Sobin LH, Sarlomo-Rikala M, et al.Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD 117(KIT). Mod Pathol, 2000,13(10) : 1134.
4Miettinen M, Virolainen M, Maarit - Sarlomo- Rikala. Gastrointesinal stromal tumors - value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol, 1995,19(2):207.
5Miettinen M, Sobin LH, Sarlomo- Rikala M. Immunohistochemical spectrum of GISTs at different sites and their differential diagnosis with a reference to CD117(KIT). Mod Pathol, 2000,13(10) : 1134.
6Sarlomo- Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Modem Pathol, 1998,11(8) :728.
7Franquemont DW. Differentiation and risk assessment of gastrointestinal stromal tumor. Am J Clin Pathol, 1995,103:41.
8Fletcher CD, Berman JJ, Corless C, et al. Diagnosis of gastrointestinal stromal tumors: a consensus approach. Hum Pathol, 2002,33:459.
9Lasota J, Jasinski M, Sarlomo - Rikala M, et al. Mutations in exon 11 of c - kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyoras or leiomyosarcomas. Am J Pathol, 1999, 154:53.
10Lux ML, Rubin BP. KIT extracellular and kinase domain mutations in gastrointestinal stromal tumor. Am J Pathol, 2000,156:791.
